Constipation Treatment Market PPT

1
Constipation Treatment Market 

• Exhibiting a CAGR of 5.6 from 2023 to 2032

2
Prime determinants of growth 

• Rise in prevalence of chronic idiopathic
  constipation, increase in number of geriatric
  populations suffering from constipation and
  availability of different drugs for treatment of
  constipation is anticipated to boost the growth
  of market. However, alternative options available
  for treatment of constipation are anticipated to
  hinder the growth of the market. On the contrary,
  the high presence of constipation drug providers,
  increase in prevalence of chronic pain and cancer
  and rise in usage of opioid is expected to
  witness growth during the forecast period.   
• The global constipation treatment market size was
  valued at 5.9 billion in 2022, and is projected
  to reach 10.1 billion by 2032, growing at a CAGR
  of 5.6 from 2023 to 2032. 

3
(No Transcript)
4
North America to maintain its dominance by 2032

• North America held the highest market share in
  terms of revenue in 2022, accounting for around
  two-fifths of the global constipation treatment
  market revenue. This is attributed to the high
  presence of constipation treatment drug
  manufacturers in North America and rising
  prevalence of chronic diseases such as cancer and
  chronic pain. However, the Asia-Pacific region is
  expected to witness the fastest CAGR of 6.4 from
  2023 to 2032 and is likely to dominate the market
  during the forecast period, owing to rising
  number of geriatric populations, as geriatric
  population is more susceptible to chronic
  diseases such as constipation, chronic pain and
  others and increase in awareness among the people
  regarding constipation treatment.     
• For Purchase Inquiry https//www.alliedmarketrese
  arch.com/purchase-enquiry/8560  

5
Leading Market Players

• Takeda Pharmaceutical Company Ltd.  
• Abbvie Inc.  
• Abbott Laboratories  
• Sanofi S.A.  
• Bausch Health Companies Inc.  
• Bayer Ag  
• Astrazeneca Plc  
• Ironwood Pharmaceuticals, Inc.  
• Prestige Consumer Healthcare Inc.  
• Ardelyx Inc.  

6
Contact

• David Correa
• 5933 NE Win Sivers Drive205, Portland,
  OR 97220United StatesToll Free
  1-800-792-5285 UK 44-845-528-1300Hong Kong
  852-301-84916India (Pune) 91-20-66346060Fax
  1-855-550-5975help_at_alliedmarketresearch.comWeb
   https//www.alliedmarketresearch.com  Follow Us
  on LinkedIn Twitter